An algorithm for the diagnosis and management of CVT:
CTV, CT venography; CVT, cerebral venous thrombosis; ICH, intracerebral
hemorrhage; LMWH, low molecular weight heparin; MRV, magnetic resonance venography; PRES, posterior reversible encephalopathy syndrome; UHF,
Table 1 Major risk factors and conditions associated with CVT
- Paranasal sinusitis
- Intracranial infections: abscess, meningitis
- Trauma Head trauma, neurosurgical operations
- Internal jugular catheter
- MEDICAL / SURGICAL CONDITIONS
- Pregnancy and puerperium
- Coagulation disorders: factor V Leiden, protein C / S deficiency, antithrombin III deficiency, hyperhomocysteinemia, APAS
- Hematologic disorders: polycythemia, sickle cell disease, TTP, polycythemia, PNH
- Malignancies, inflammatory bowel disease, nephrotic syndrome, liver cirrhosis, collagen vascular disease including SLE, Wegener’s granulomatosis and Behçet syndrome
- Previous surgical procedures
- Oral contraceptives, hormone replacement therapy, L-asparagenase, corticosteroid
Table 3 Clinical presentations of CVT:
- Double or blurred vision
- Altered consciousness
- Behavioral symptoms (delirium, amnesia, mutism)
- Focal neurologic deficit
- Cranial nerve palsy
Society of Neurointerventional Surgery (SNIS) Recommendations:
► A combination of MRI/MRV or CT/CTV studies should be performed in patients with suspected CVT (class I; level of evidence C).
► DSA as a diagnostic modality is indicated in cases of suspected CVT when the diagnosis of CVT cannot be reliabl established with non-invasive imaging alone (class IIa; level of evidence C).
Medical and surgical treatment
► Anticoagulation with unfractionated heparin or low molecular weight heparin is reasonable in patients with CVT (class IIa; level of evidence C).
► Decompressive craniectomy may be considered in patients with large parenchymal lesions causing herniation or intractable intracranial hypertension (class IIb; level of evidence C).
► Endovascular therapy may be considered in patients with clinical deterioration despite anticoagulation, or with severe neurological deficits or coma (class IIb; level of evidence C). The duration of anticoagulation therapy before declaring it to be a ‘failure’ and proceeding with endovascular therapy is unknown.
► There is insufficient evidence to determine which endovascular approach and device provides the optimal restoration of venous outflow in CVT. In many cases, a variety of treatment approaches is required to establish sinus patency.
Radiologic Findings in CVT:
- noncontrast CT – hyperdensity of occluded sinuses + cerebral edema +/- ICH
- contrast CT – empty delta sign, HU>70% highly specific for acute CVT
- MRI – T2 hypointensity in acute CVT, T1 and T2 hyperintensity in subacute CVT
Lee, S., Mokin, M., Hetts, S., Fifi, J., Bousser, M. and Fraser, J. (2018). Current endovascular strategies for cerebral venous thrombosis: report of the SNIS Standards and Guidelines Committee. Journal of NeuroInterventional Surgery, 10(8), pp.803-810.